We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Anticholinergic Use With Incident Dementia

Roy Fried, MD, MHS1
[+] Author Affiliations
1Premier Senior Care, Bethesda, Maryland
JAMA Intern Med. 2015;175(9):1577. doi:10.1001/jamainternmed.2015.2565.
Text Size: A A A
Published online


To the Editor The report by Gray et al1 on the association of anticholinergic use with incident dementia may have overestimated the risk of anticholinergic use due to residual confounding. Participants with the highest level of cumulative exposure had, at baseline, more than double the rate of stroke and triple the rate of fair or poor health by self-report than participants with no exposure. They also had higher rates of hypertension, diabetes mellitus, and obesity; were twice as likely to be women; and 4 times as likely to have high levels of depressive symptoms. Since these independent risks for dementia were present at baseline and were correlated with anticholinergic exposure, the anticholinergic-dementia association may reflect residual confounding and could persist despite lag-time analysis, which discounts exposure only in the 2 years prior to dementia onset. Stratified analyses limited to women or men who were free of these potential confounders at study entry may reduce error due to residual confounding and give more accurate estimates of effect size.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 1, 2015
Shelly L. Gray, PharmD, MS; Melissa Anderson, MS; Rebecca Hubbard, PhD
1School of Pharmacy, University of Washington, Seattle
2Group Health Research Institute, Seattle, Washington
3Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
JAMA Intern Med. 2015;175(9):1577. doi:10.1001/jamainternmed.2015.2574.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...